Biblio
Export 47 results:
Author Keyword Title Type [ Year
Filters: First Letter Of Title is U [Clear All Filters]
“Undiagnosed Dementia Is Associated with Poor Physical Function in Older Adults.”, J Alzheimers Dis, vol. 89, no. 2, pp. 473-482, 2022.
, “Upregulation of Cortical A2A Adenosine Receptors Is Reflected in Platelets of Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 80, no. 3, pp. 1105-1117, 2021.
, “Upregulation of Local Hepcidin Contributes to Iron Accumulation in Alzheimer's Disease Brains.”, J Alzheimers Dis, vol. 82, no. 4, 2021.
, “Urban Air Pollution Nanoparticles from Los Angeles: Recently Decreased Neurotoxicity.”, J Alzheimers Dis, vol. 82, no. 1, pp. 307-316, 2021.
, “Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo Compared to Histology.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1481-1499, 2020.
, “Use of Immersive Virtual Reality in the Assessment and Treatment of Alzheimer's Disease: A Systematic Review.”, J Alzheimers Dis, vol. 75, no. 1, pp. 23-43, 2020.
, “Using Machine Learning to Predict Dementia from Neuropsychiatric Symptom and Neuroimaging Data.”, J Alzheimers Dis, vol. 75, no. 1, pp. 277-288, 2020.
, “Utility of MemTrax and Machine Learning Modeling in Classification of Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 77, no. 4, pp. 1545-1558, 2020.
, “Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease.”, J Alzheimers Dis, vol. 71, no. 3, pp. 775-783, 2019.
, “An UNC5C Allele Predicts Cognitive Decline and Hippocampal Atrophy in Clinically Normal Older Adults.”, J Alzheimers Dis, vol. 68, no. 3, pp. 1161-1170, 2019.
, “Understanding the Amyloid Hypothesis in Alzheimer's Disease.”, J Alzheimers Dis, vol. 68, no. 2, pp. 493-510, 2019.
, “Upregulation of Thioredoxin-Interacting Protein in Brain of Amyloid-β Protein Precursor/Presenilin 1 Transgenic Mice and Amyloid-β Treated Neuronal Cells.”, J Alzheimers Dis, vol. 72, no. 1, pp. 139-150, 2019.
, “Ubisol-Q10 (a Nanomicellar Water-Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 1, pp. 221-236, 2018.
, “Underlying Biological Processes in Mild Cognitive Impairment: Amyloidosis Versus Neurodegeneration.”, J Alzheimers Dis, vol. 64, no. s1, pp. S647-S657, 2018.
, “Understanding Epigenetics in the Neurodegeneration of Alzheimer's Disease: SAMP8 Mouse Model.”, J Alzheimers Dis, vol. 62, no. 3, pp. 943-963, 2018.
, “The Unexpected Role of Aβ1-42 Monomers in the Pathogenesis of Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1241-1245, 2018.
, “The Uniform Data Set, Czech Version: Normative Data in Older Adults from an International Perspective.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1233-1240, 2018.
, “Untold New Beginnings: Adult Hippocampal Neurogenesis and Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. s1, pp. S497-S505, 2018.
, “Unusual Clinical Presentations Challenging the Early Clinical Diagnosis of Creutzfeldt-Jakob Disease.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1051-1065, 2018.
, “Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1417-1441, 2018.
, “Urine-Based Biomarkers for Alzheimer's Disease Identified Through Coupling Computational and Experimental Methods.”, J Alzheimers Dis, vol. 65, no. 2, pp. 421-431, 2018.
, “The Use of Mobile Games to Assess Cognitive Function of Elderly with and without Cognitive Impairment.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1285-1293, 2018.
, “Usefulness of Dual-Point Amyloid PET Scans in Appropriate Use Criteria: A Multicenter Study.”, J Alzheimers Dis, vol. 65, no. 3, pp. 765-779, 2018.
, “Using Neuropsychological Process Scores to Identify Subtle Cognitive Decline and Predict Progression to Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 64, no. 1, pp. 195-204, 2018.
, “Utility of Amyloid and FDG-PET in Clinical Practice: Differences Between Secondary and Tertiary Care Memory Units.”, J Alzheimers Dis, vol. 63, no. 3, pp. 1025-1033, 2018.
,